Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,196.00
(
-1.18%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
104.46
(
-1.23%
)
Bitcoin
80,995.01
(
0.63%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Couch

Send PM Follow Ignore
Followers 280
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Couch

Re: Protector post# 267237

Thursday, 06/23/2016 3:50:55 PM

Thursday, June 23, 2016 3:50:55 PM

Post# of 347009

Quote:
Planned studies include bavituximab in combination with pembrolizumab in hepatocellular carcinoma, and durvalumab in NSCLC.


Anybody have any info on when the "planned studies" are to move forward???

AND am I to assume a study in less than a phase trial???

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote